• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人卵巢癌细胞系中p53基因的异常结构与表达

Abnormal structure and expression of the p53 gene in human ovarian carcinoma cell lines.

作者信息

Yaginuma Y, Westphal H

机构信息

Laboratory of Mammalian Genes and Development, National Institute of Child Health and Human Development, NIH, Bethesda, Maryland 20892.

出版信息

Cancer Res. 1992 Aug 1;52(15):4196-9.

PMID:1638534
Abstract

In an effort to analyze molecular mechanisms of human ovarian carcinogenesis, we studied the structure and expression of the p53 gene in different cell lines established from human ovarian carcinomas. In all six lines (PA-1, Caov-3 and -4, OVCAR-3, SK-OV-3, and Kuramochi), p53 abnormalities were detected. In the SK-OV-3 cell line, Southern analysis suggested the presence of sequence deletions/rearrangements in at least one allele of the p53 gene, and transcripts were not detectable by either Northern or polymerase chain reaction analysis. Sequence analysis of the entire coding region of the p53 gene revealed point mutations resulting in codon changes of a highly conserved region of the protein in four cell lines, Caov-3 and -4, OVCAR-3, and Kuramochi. In the Caov-3 cell line, the point mutation resulted in chain termination at codon 136. Quantitation of p53 protein by immunoprecipitation analysis revealed a 6-fold higher than control cell level in PA-1. By contrast, p53 protein was not detectable in lines Caov-3 and SK-OV-3. We conclude that altered levels of p53 gene expression and/or mutant forms of the p53 gene product are associated with all human ovarian cancer cells tested.

摘要

为了分析人类卵巢癌发生的分子机制,我们研究了从人类卵巢癌建立的不同细胞系中p53基因的结构和表达。在所有六个细胞系(PA-1、Caov-3和-4、OVCAR-3、SK-OV-3和仓持)中,均检测到p53异常。在SK-OV-3细胞系中,Southern分析表明p53基因至少一个等位基因存在序列缺失/重排,Northern或聚合酶链反应分析均未检测到转录本。对p53基因整个编码区的序列分析显示,在四个细胞系Caov-3和-4、OVCAR-3和仓持中存在点突变,导致该蛋白高度保守区域的密码子发生变化。在Caov-3细胞系中,点突变导致密码子136处的链终止。通过免疫沉淀分析对p53蛋白进行定量,结果显示PA-1中的p53蛋白水平比对照细胞高6倍。相比之下,在Caov-3和SK-OV-3细胞系中未检测到p53蛋白。我们得出结论,p53基因表达水平的改变和/或p53基因产物的突变形式与所有测试的人类卵巢癌细胞相关。

相似文献

1
Abnormal structure and expression of the p53 gene in human ovarian carcinoma cell lines.人卵巢癌细胞系中p53基因的异常结构与表达
Cancer Res. 1992 Aug 1;52(15):4196-9.
2
Analysis of the Rb gene and cyclin-dependent kinase 4 inhibitor genes (p16INK4 and p15INK4B) in human ovarian carcinoma cell lines.人卵巢癌细胞系中Rb基因及细胞周期蛋白依赖性激酶4抑制基因(p16INK4和p15INK4B)的分析
Exp Cell Res. 1997 Jun 15;233(2):233-9. doi: 10.1006/excr.1997.3560.
3
[Analysis of p53 gene in gynecologic tumors].
Rinsho Byori. 1994 Mar;42(3):235-41.
4
p53 gene mutations in gastric cancer metastases and in gastric cancer cell lines derived from metastases.
Cancer Res. 1991 Nov 1;51(21):5800-5.
5
Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.卵巢癌细胞系中顺铂耐药与p53基因突变及bax表达降低之间的关联。
Cancer Res. 1996 Feb 1;56(3):556-62.
6
p53 gene mutation analysis and antisense-mediated growth inhibition of human ovarian carcinoma cell lines.人卵巢癌细胞系的p53基因突变分析及反义介导的生长抑制
Gynecol Oncol. 1996 Jan;60(1):72-80. doi: 10.1006/gyno.1996.0014.
7
Mutation of the p53 gene in a differentiated human thyroid carcinoma cell line, but not in primary thyroid tumours.p53基因在一种分化型人甲状腺癌细胞系中发生突变,但在原发性甲状腺肿瘤中未发生突变。
Oncogene. 1991 Sep;6(9):1693-7.
8
3-Methylcholanthrene inactivates the p53 gene in Syrian hamster embryo fibroblasts by inducing a specific intronic point mutation.
Cancer Res. 1994 Aug 15;54(16):4502-7.
9
Human pancreatic carcinomas and cell lines reveal frequent and multiple alterations in the p53 and Rb-1 tumor-suppressor genes.人类胰腺癌及癌细胞系显示出p53和Rb-1肿瘤抑制基因频繁且多处发生改变。
Oncogene. 1992 Aug;7(8):1503-11.
10
Mutation analysis of the THRA1 gene in breast cancer: deletion/fusion of the gene to a novel sequence on 17q in the BT474 cell line.乳腺癌中THRA1基因的突变分析:BT474细胞系中该基因与17号染色体上一个新序列的缺失/融合
Cancer Res. 1994 Apr 1;54(7):1791-4.

引用本文的文献

1
New anti-ovarian cancer quinolone derivatives acting by modulating microRNA processing machinery.通过调节微小RNA加工机制发挥作用的新型抗卵巢癌喹诺酮衍生物
RSC Med Chem. 2024 Sep 27;16(1):98-124. doi: 10.1039/d4md00649f.
2
Deciphering the ghost proteome in ovarian cancer cells by deep proteogenomic characterization.通过深度蛋白质基因组特征分析破译卵巢癌细胞中的幽灵蛋白质组。
Cell Death Dis. 2024 Sep 30;15(9):712. doi: 10.1038/s41419-024-07046-1.
3
Evaluating the specific STAT3 inhibitor YHO-1701 in ovarian cancer cell lines and patient-derived cell models: efficacy, mechanisms, and therapeutic potential.
评估特异性信号转导与转录激活因子3(STAT3)抑制剂YHO-1701在卵巢癌细胞系和患者来源细胞模型中的作用:疗效、作用机制及治疗潜力。
J Gynecol Oncol. 2025 Mar;36(2):e24. doi: 10.3802/jgo.2025.36.e24. Epub 2024 Aug 2.
4
Chromosomal copy number and mutational status are required to authenticate ovarian cancer cell lines as appropriate cell models.染色体拷贝数和突变状态是鉴定卵巢癌细胞系作为适当细胞模型的必要条件。
Mol Biol Rep. 2024 Jun 28;51(1):784. doi: 10.1007/s11033-024-09747-4.
5
Targeting polyploid giant cancer cells potentiates a therapeutic response and overcomes resistance to PARP inhibitors in ovarian cancer.针对多倍体巨癌细胞可增强治疗反应,并克服卵巢癌对 PARP 抑制剂的耐药性。
Sci Adv. 2023 Jul 21;9(29):eadf7195. doi: 10.1126/sciadv.adf7195.
6
Drug toxicity assessment: cell proliferation versus cell death.药物毒性评估:细胞增殖与细胞死亡
Cell Death Discov. 2022 Oct 14;8(1):417. doi: 10.1038/s41420-022-01207-x.
7
PVT1 is a stress-responsive lncRNA that drives ovarian cancer metastasis and chemoresistance.PVT1 是一种应激反应性 lncRNA,可促进卵巢癌转移和化疗耐药。
Life Sci Alliance. 2022 Jul 12;5(11). doi: 10.26508/lsa.202201370. Print 2022 Nov.
8
Expression Profiles of ID and E2A in Ovarian Cancer and Suppression of Ovarian Cancer by the E2A Isoform E47.ID和E2A在卵巢癌中的表达谱以及E2A亚型E47对卵巢癌的抑制作用
Cancers (Basel). 2022 Jun 12;14(12):2903. doi: 10.3390/cancers14122903.
9
Heterogeneous Ribonucleoprotein A1 (hnRNPA1) Interacts with the Nucleoprotein of the Influenza a Virus and Impedes Virus Replication.异质核糖核蛋白 A1(hnRNPA1)与甲型流感病毒的核蛋白相互作用并阻碍病毒复制。
Viruses. 2022 Jan 20;14(2):199. doi: 10.3390/v14020199.
10
Platelet-activating factor acetyl hydrolase IB2 dysregulated cell proliferation in ovarian cancer.血小板活化因子乙酰水解酶IB2在卵巢癌中使细胞增殖失调。
Cancer Cell Int. 2021 Dec 20;21(1):697. doi: 10.1186/s12935-021-02406-9.